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Abstract
Background: In patients who recover consciousness after cardiac arrest (CA), a subsequent death from non-neurological
causes may confound the assessment of long-term neurological outcome. We investigated the prevalence and causes of
death after awakening (DAA) in a multicenter cohort of CA patients.
Methods: Observational multicenter cohort study on patients resuscitated from CA in eight European intensive care units
(ICUs) from January 2007 to December 2014. DAA during the hospital stay was extracted retrospectively from patient
medical records. Demographics, comorbidities, initial CA characteristics, concomitant therapies, prognostic tests (clinical
examination, electroencephalography (EEG), somatosensory evoked potentials (SSEPs)), and cause of death were identified.
Results: From a total 4646 CA patients, 2478 (53%) died in-hospital, of whom 196 (4.2%; ranges 0.6–13.0%) had DAA.
DAA was less frequent among out-of-hospital than in-hospital CA (82/2997 [2.7%] vs. 114/1649 [6.9%]; p < 0.001).
Median times from CA to awakening and from awakening to death were 2 [1–5] and 9 [3–18] days, respectively.
The main causes of DAA were multiple organ failure (n = 61), cardiogenic shock (n = 61), and re-arrest (n = 26).
At day 3 from admission, results from EEG (n = 56) and SSEPs (n = 60) did not indicate poor outcome.
Conclusions: In this large multicenter cohort, DAA was observed in 4.2% of non-survivors. Information on DAA is
crucial since it may influence epidemiology and the design of future CA studies evaluating neuroprognostication and
neuroprotection.
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Introduction
Despite continuous medical advances, the majority of pa-
tients who are initially resuscitated from cardiac arrest
(CA) and admitted to the hospital die because of irrevers-
ible hypoxic-ischemic encephalopathy (HIE) [1, 2]. As
such, research has focused predominantly on the imple-
mentation of potential neuroprotective strategies, like tar-
geted temperature management (TTM) [3], as well as on
the improvement of prognostication tools to early identify
those patients with severe HIE [4, 5].
Around one third of deaths after CA are due to non-
neurological causes, such as cardiogenic shock, sepsis, or
multiple organ failure (MOF). Most of these deaths
occur during the first 3 days after the return of
spontaneous circulation (ROSC), which is earlier than
HIE-related deaths [1]. However, delayed deaths from
non-neurological causes, i.e., after TTM is discontinued,
have been described [6]. Death after awakening (DAA)
from post-anoxic coma may thus be misclassified as
“neurological” death, since commonly used scores to as-
sess long-term neurological recovery do not clearly
distinguish between neurological and non-neurological
causes of death. In one recent study, 16% of the CA
patients who eventually died after ICU admission had
recovered consciousness during their ICU stay [7].
Nevertheless, neurological assessment was limited, and
no specific information on the results of additional prog-
nostic tools was provided. This lack of consistency in
outcome reporting after CA was also underlined by the
Core Outcome Set for Cardiac Arrest (COSCA) initia-
tive, which recently refined recommendations for how
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and when outcomes after CA should be measured and
reported [8].
Thus, we developed this project called “Best CPC” (i.e.,
as for Cerebral Performance Category) with the aim to as-
sess the prevalence of DAA in CA patients before hospital
discharge. Moreover, we aimed to identify the characteris-
tics of these patients, including predictors of neurological
recovery, as we hypothesized that they might show no
signs of poor outcome.
Methods
Study population
We retrospectively analyzed the institutional databases
of eight academic ICUs where comatose CA survivors
(i.e., a Glasgow Coma Scale < 9 at hospital admission)
were admitted over the study period (January 2007 to
December 2014). Among patients who died prior to hos-
pital discharge, DAA was defined as a patient who was
able to obey commands and open his/her eyes during
the ICU stay but eventually died before hospital dis-
charge for any reason, including a new neurological
event. The local ethical committees in each country ap-
proved the study and waived the need for informed con-
sent because of its retrospective nature.
Patient management
All comatose patients were treated according to local
protocols. Sedation policies, the site of temperature
monitoring, and the specific findings on hemodynamic
or ventilator management were not collected. Blood glu-
cose levels were kept between 110 and 150 mg/dL using
continuous intravenous insulin administration. A mean
arterial pressure of at least 65–70 mmHg was main-
tained using volume resuscitation, dobutamine, and/or
norepinephrine, whenever needed. Enteral nutrition was
initiated according to local practice.
Withdrawal of life-sustaining therapies (WLST) was
based on an interdisciplinary approach, involving intensi-
vists and neurologists. Strong predictors of poor outcome
were considered the bilateral absence of the N20 cortical
responses to sensory evoked potentials (SSEPs) or persist-
ing coma with poor motor response and absent brainstem
reflexes at 3 days or more after CA. Less strong predictors
(i.e., early status myoclonus, refractory status epilepticus,
or elevated neuron-specific enolase (NSE) levels) were also
considered, when available, in case of prolonged coma
within a collegial agreement for WLST.
Data collection
For each patient with DAA, demographics (including age,
gender) and comorbid diseases (i.e., NYHA III-IV heart
disease, COPD/asthma, diabetes, chronic renal failure re-
quiring hemodialysis, liver cirrhosis, immunosuppression,
previous neurological diseases such as cerebrovascular
diseases, neurodegenerative diseases, or seizures) were re-
corded. Cardiac arrest variables according to the Utstein
style (i.e., witnessed status, bystander CPR, location, time
from arrest to ROSC, cardiac vs. non-cardiac causes of
CA, initial rhythm) were collected [9, 10]. Time from ar-
rest to neurological recovery as well as time from neuro-
logical recovery to death was recorded. Death was defined
post hoc as “early” if it occurred within 9 days from arrest,
according to the median time from arrest to awakening
(see the “Results” section). Specific therapies during the
ICU stay, including TTM (32–36 °C), vasopressors, ino-
tropic agents, mechanical ventilation, renal replacement
therapy (RRT), intra-aortic balloon pump counterpulsa-
tion (IABP), or extracorporeal membrane oxygenation
(ECMO), were also collected. Overall ICU length of stay,
the occurrence and site of infection, and presumed cause
for death were reported for each patient.
Additional prognostic data, whenever available, included
clinical examination (i.e., motor score of the Glasgow
Coma Scale, with absent or posturing motor response de-
fined as “poor”; absence of pupillary reflexes; myoclonus)
and EEG (i.e., “highly malignant” EEG patterns [11], ab-
sence of reactivity to painful stimuli, seizures or status
epilepticus) both on day 1 or at days 2–3 after arrest. EEG
findings were collected from the daily report of neurolo-
gists in the medical record of each patient, and tracings
were not re-analyzed. The presence of N20 cortical re-
sponse of somato-sensory evoked potentials (SSEPs) was
recorded as well as time from arrest to SSEPs. The highest
NSE during the ICU stay was also collected. Results and
timing of brain imaging (i.e., brain CT scan or magnetic
resonance imaging (MRI)) were recorded.
Statistical analysis
Statistical analyses were performed using IBM SPSS Statis-
tics 24.0 for Windows. Descriptive statistics were com-
puted for all study variables and normal distribution was
assessed using the Kolmogorov–Smirnov test. Data are
presented as count (percentage) or median [25th–75th
percentiles]. Comparison between subgroups (IHCA vs.
OHCA) was performed using the χ2 test or Mann-Whitney
test, as appropriate. A p value < 0.05 was considered as
significant.
Results
A total of 4646 patients were admitted after successful
resuscitation of a CA in the participating centers over
the study period; of those, 2997 (64%) were OHCA and
non-survivors were 2478 (53%). Main differences among
centers are reported in Table 1.
A total of 196 (4.2%) patients were identified among
non-survivors as DAA; the proportion of these patients
varied from 0.6 to 13.0% among centers. In 38 (19%)
patients, DAA occurred after ICU discharge. The
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characteristics of the study cohort are shown in Table 2;
82 (42%) patients had an OHCA. DAA was less common
among OHCA than among IHCA patients (82/2997 vs.
114/1649; p < 0.001). In the group of DAA patients after
OHCA, heart failure, COPD/asthma, and the use of
chronic hemodialysis, bystander CPR, and an initial
non-shockable rhythm were less frequent than in the
IHCA group. DAA patients from OHCA also had a longer
time of ROSC, received more adrenaline, were more fre-
quently treated with TTM, and experienced more shock
than DAA patients after IHCA (Table 2).
The median time from arrest to awakening was 2
[1–5] days; a large variability in time of awakening was
observed among centers (Table 1). The time from arrest
to awakening was similar in OHCA and IHCA patients
(3 [1–5] vs. 2 [1–5] days; p = 0.77). The median time
from awakening to death was 9 [3–18] days (9 [1–19] in
OHCA vs. 9 [3–16] days in IHCA; p = 0.90). The causes
of death in DAA were multiple organ failure (MOF)
(n = 61), cardiogenic shock (n = 61), re-arrest (n = 26),
severe acute respiratory distress syndrome (n = 20),
sepsis/septic shock (n = 18), new diagnosis or ongoing
cancer (n = 5), mesenteric ischemia (n = 3), and severe
bleeding or pulmonary embolism (n = 1 each). The dis-
tribution of different causes of death showed that
cardiogenic shock and re-arrest were more frequent
among early non-survivors (n = 101), while sepsis/ARDS
were more frequent among late non-survivors (Fig. 1;
p = 0.008). The distribution of causes of death was
similar between IHCA and OHCA patients (Fig. 2).
Main findings of clinical examination and additional
prognostication tools in patients with DAA are reported
in Table 3. On day 1 after admission, most patients
(76%) presented a poor motor response and 38% had bi-
lateral absence of pupillary reflexes. EEG was performed
in only 30 (15%) patients; burst-suppression or sup-
pressed EEG tracing was found in 3 (9%) patients, while
most had a continuous (n = 21) or discontinuous (n = 6)
background. Median NSE levels were 16 [15–27] μg/L,
with only 1 patient exceeding 50 μg/L. A brain CT scan
was performed in 52 (26%) patients; 2 abnormal CT find-
ings were identified (subarachnoid hemorrhage and sub-
dural hematoma). On day 3 after admission, clinical
examination was available for 167 (85%) patients, because
of some early deaths. Thirteen (8%) patients presented bi-
laterally absent pupillary reflexes. EEG was available in 56
patients, with 52 of them having a continuous and 4 of
them a discontinuous background. NSE levels were 17
[14–27] μg/L, with only 1 patient exceeding 50 μg/L.
Somato-sensory evoked potential were performed in 60
patients after a median of 4 [3, 4] days since the cardiac
arrest; none of these patients had bilaterally absent cortical
N20 responses.
Discussion
The results of this multicenter study showed that 4.2%
of comatose CA survivors admitted to ICU die after
regaining consciousness. We also observed large vari-
ability of DAA between participating centers. Most of
these patients showed signs predicting good neurological
outcome during the first 3 days after admission.
Re-arrest was the most common cause of DAA in the
early phase after CA while ARDS and sepsis were the
most common causes of death thereafter.
Several studies have reported post-arrest shock, MOF,
and other non-neurological conditions as the main
causes of death in about one third of OHCA patients [2,
12, 13]. Nevertheless, no specific data on the occurrence
of death among patients who eventually regained con-
sciousness after the initial anoxic injury are available. In
one study evaluating two different cooling strategies
after OHCA [14], Deye et al. reported that a favorable
neurological outcome was observed in 113 patients at
day 90 after ROSC; 16 patients (4%), who initially had
recovered neurological function, had died from
non-cerebral causes at that time point. Also, Nobile et
al. showed that, among 210 patients who died in the
ICU after initial resuscitation from CA, 33 (16%) of
them showed signs of improved neurological function,
assessed by the Glasgow Coma Scale, prior to death.
Table 1 Main differences among participating centers. Data are presented as count (%) or median (ranges). The percentage of DAA
is calculated on the total number of CA admissions
Total (n = 4646) OHCA/IHCA (n = 2997/n = 1649) Non-survivors (n = 2478) DAA (n = 196) % of DAA Time of awakening (days)
Center 1 778 762/16 515 (66%) 5 0.6 1 (1–1)
Center 2 384 244/140 207 (54%) 50 13.0 1 (1–42)
Center 3 408 211/187 235 (58%) 19 4.7 3 (1–9)
Center 4 393 274/118 237 (60%) 23 5.9 2 (1–7)
Center 5 598 420/178 284 (47%) 18 3.0 8 (3–44)
Center 6 311 273/38 148 (48%) 12 3.9 4 (2–8)
Center 7 1510 743/767 671 (44%) 45 3.0 2 (1–10)
Center 8 275 70/205 181 (66%) 24 8.7 5 (1–21)
DAA death after awakening, OHCA out-of-hospital cardiac arrest, IHCA in-hospital cardiac arrest
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These patients presented more frequently with renal,
cardiovascular, and respiratory failure than ICU survi-
vors with good neurological function, and the authors
concluded that extra-cerebral organ dysfunction may
have resulted in their poor outcome [7]. Our multicenter
study confirms that a proportion of non-survivors show
neurological recovery prior to death before hospital dis-
charge; this best neurological status of CA patients
should be reported in all studies to better characterize
the evolution of such patients, in particular if neuropro-
tective interventions are evaluated. In the recent COSCA
recommendations on outcome reporting after CA [8],
Table 2 Characteristics of study population on admission and during the ICU stay. Data are presented as counts (percentage) or
median [IQRs]
All (n = 196) OHCA (n = 82) IHCA (n = 114)
Male, n (%) 132 (67) 60 (72) 72 (63)
Age, years 73 [62–79] 73 [65–79] 73 [60–79]
Estimated weight, kg 75 [70–85] 75 [70–82] 76 [70–89]
Comorbidities
Chronic hypertension 75 (38) 29 (35) 46 (40)
Diabetes 60 (31) 24 (29) 36 (32)
NYHA III–IV heart failure 27 (14) 6 (7) 21 (18) *
Chronic coronary artery disease 86 (44) 32 (39) 54 (47)
Previous vascular neurological disease 32 (16) 18 (22) 14 (12)
Liver cirrhosis 17 (9) 4 (5) 13 (11)
COPD/asthma 50 (26) 14 (17) 36 (32) *
Chronic hemodialysis 30 (15) 7 (9) 23 (20) *
Immunosuppression 10 (5) 4 (5) 6 (5)
CA characteristics
Time of ROSC, min 12 [6–20] 17 [12–25] 10 [5–15] *
Adrenaline, mg 2 [1–3] 3 [1–4] 1 [1–1] *
Witnessed, n (%) 167 (85) 66 (80) 101 (89)
Bystander CPR, n (%) 147 (75) 52 (63) 95 (83) *
Cardiac cause, n (%) 152 (78) 60 (73) 92 (81)
Non-shockable rhythm, n (%) 127 (65) 43 (52) 84 (74) *
ECPR, n (%) 15 (8) 5 (6) 10 (9)
After hospital admission
Lactate on admission, mmol/dL 5.4 [2.9–8.4] 5.7 [2.9–8.4] 5.2 [2.9–8.4]
Vasopressor use, n (%) 178 (91) 74 (90) 104 (91)
Dobutamine use, n (%) 107 (55) 44 (54) 63 (55)
TTM, n (%) 117 (60) 66 (80) 51 (45) *
Infection, n (%) 89 (45) 36 (44) 53 (46)
Shock, n (%) 148 (76) 69 (84) 79 (69) *
IABP, n (%) 16 (8) 6 (7) 10 (9)
Post-ROSC ECMO, n (%) 13 (7) 3 (4) 10 (9)
RRT, n (%) 71 (36) 17 (21) 54 (47) *
MV, n (%) 195 (99) 82 (100) 113 (99)
Bleeding, n (%)$ 48 (24) 16 (20) 32 (28)
ICU length of stay, days 8 [3–16] 9 [1–16] 7 [3–15]
ECPR extracorporeal cardiopulmonary resuscitation, ECMO extra-corporeal membrane oxygenation, ICU intensive care unit, NYHA New York Heart Association, COPD
chronic pulmonary obstructive disease, CA cardiac arrest, IABP intra-aortic balloon counterpulsation, TTM targeted temperature management, RRT renal replacement
therapy, MV mechanical ventilation
$Reduction of hemoglobin of at least 2 g/dL over 24 h requiring red blood cells transfusion
*p < 0.05 between IHCA and OHCA
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Fig. 1 Distribution of different causes of death, according to early (≤ 9 days since neurological recovery) or late (> 9 days since neurological
recovery) death
Fig. 2 Distribution of different causes of death, according to in-hospital (IHCA) or out-of-hospital cardiac arrest (OHCA)
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the need for early report on survival and neurological
outcome was also underlined, although no specific defin-
ition was given. We used the term of DAA, although
“Best CPC” (i.e., the lowest CPC score obtained during
the entire ICU and hospital stay on a daily clinical as-
sessment) or “CPC 6” (i.e., death for all causes after
regaining consciousness in contrast with CPC 5, which
would identify all non-survivors without regaining con-
sciousness prior to death) could also be valuable alterna-
tive definitions of this finding.
Although non-cerebral causes of death have been de-
scribed in earlier studies, we specifically reported their oc-
currence according to the timing from arrest to death. As
expected, in the early phase, more than 60% of deaths
were due to MOF and cardiogenic shock. Interestingly,
20% of patients with DAA died because of re-arrest. The
incidence of re-arrest among patients immediately after
ROSC can be as high as 80%, particularly in patients with
shockable rhythms in the pre-hospital setting, although
this might represent a non-sustained ROSC [15]. Also,
while the incidence of re-arrest has been documented in
the pre-hospital setting immediately after ROSC in up to
10% of patients [16], no previous reports have described
the occurrence of re-arrest after hospital admission. We
do not have enough data to conclude whether re-arrest in
our cohort resulted from persistent circulatory failure,
coronary lesion without effective revascularization, or if it
was an unexpected complication (i.e., malignant arrhyth-
mias) in hemodynamically stable patients. Among late
deaths, 55% of them were still caused by MOF and cardio-
genic shock and 26% by sepsis or ARDS while 3 patients
had mesenteric ischemia. Sepsis-associated CA, in par-
ticular after IHCA, is a relatively common complication,
which is associated with very low survival rates [17]. CA
itself is considered a “sepsis-like” syndrome with a high
degree of inflammation, organ dysfunction, and microcir-
culatory abnormalities that can significantly contribute to
post-resuscitation mortality [18, 19]. In the TTM study,
500 out of 939 patients (53%) developed pneumonia, se-
vere sepsis, or septic shock, which was associated with an
increased mortality in a multivariate analysis [20]. In the
Intensive Care Over Nations (ICON) database, 43% of all
CA patients (n = 469) developed an infection during the
ICU stay and 28% were in septic shock [8]; in the multi-
variable analysis, sepsis was also an independent predictor
of ICU mortality. The occurrence of ARDS is a less com-
mon event after CA; 3 to 7% of patients presented this
complication in a database including 812 resuscitated pa-
tients from 1998 to 2010 [21]. Nevertheless, this low rate
might be due to the stringent definition criteria used in
this study, as respiratory failure has been reported in up to
50–80% of CA patients admitted to the ICU [8, 22]. Fi-
nally, an intestinal injury is frequent after CA and is asso-
ciated with the occurrence of endotoxemia, which might
contribute to the worsening of post-resuscitation shock
and the occurrence of organ failure [23]. However, the
pathophysiology of this complication is poorly understood
and its occurrence extremely rare [24]. As such, DAA oc-
curs as the result of the ongoing disease or cardiac ische-
mia in the early phase after CA, while late deaths are
usually due to the same causes as in non-CA ICU pa-
tients, i.e. infections and pulmonary problems. The pres-
ence of these potentially treatable causes of death, such as
unexpected re-arrest, sepsis, or ARDS, underlines the im-
portance of accurate monitoring and surveillance of CA
survivors in the early phase. Future research should focus
on the epidemiology of DAA in this setting, as well as the
potential preventive and therapeutic measures to avoid
these deaths (i.e., early coronary angiography, protective
ventilation, digestive decontamination). Interestingly, in
19% of patients, DAA occurred after ICU discharge. This
may suggest that those patients had shown full recovery of
all acute dysfunction following CA and could be trans-
ferred to the ward; as such, DAA occurred for an unpre-
dictable and new complication. Nevertheless, it is also
possible that some limitations to an ICU re-admission
could have been decided by ICU physicians; this decision
may have resulted in death for a potentially treatable path-
ology that occurred in a patient with several comorbidities
or a poor performance status.
The main impact of DAA concerns the evaluation of
neuroprotective therapies and the assessment of neuro-
logical prognosis. Indeed, if a neuroprotective drug
would show benefit and provide more patients recover-
ing consciousness after the initial HIE, the assessment of
neurological outcome few months after the initial event
would be inadequate to demonstrate these effects, if
Table 3 Prognostic findings of the study cohort. Data are
presented as counts (percentage) or median [IQRs]
Day 1 Days 2–3
n n
Motor response 196 1 [1–2] 167 5 [2–6]
M1–2 MR, n (%) 196 148 (76) 167 43 (26)
Bilateral absent PR, n (%) 196 74 (38) 160 13 (8)
Myoclonus, n (%) 196 3 (2) 167 0 (0)
Clinical seizures, n (%) 196 0 (0) 167 3 (2)
Continuous EEG, n (%) 30 21 (70) 56 52 (96)
BS/Suppressed EEG, n (%) 30 3 (9) 56 0 (0)
Reactive EEG, n (%) 26 22 (85) 44 40 (91)
NSE levels, μg/L 22 16 [15–27] 37 17 [14–27]
Abnormal brain CT-scan, n (%) 52 2 (4) 12 2 (16)
Bilaterally absent N20, n (%) – – 60 0 (0)
M1–2 absent motor response or posturing, MR motor response, PR pupillary
reflexes, EEG electroencephalography, BS burst suppression, NSE neuron-specific
enolase, CT computed tomography, N20 cortical response to somato-sensory
evoked potentials on the median nerve
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patients die early from non-cerebral causes. Thus, DAA is
a relevant “early” outcome to be reported together with
long-term neurological outcome, quality of life, and cogni-
tive function among CA survivors [8, 25]. In addition, if
not properly addressed, DAA may cause false-positive re-
sults and reduce the prognostic accuracy of outcome pre-
dictors after CA [26–28]. We consider that future studies
on prognostication tools and strategies should report the
occurrence of DAA and exclude those patients who die in
the very early phase after admission without a neuro-
logical examination, as they represent a source of potential
bias for the interpretation of these results.
Some limitations of our study deserve discussion. First,
the retrospective design might have produced an under-
estimation of DAA in these patients. Prospective, specific-
ally designed studies will be needed to address this
potential bias. However, should this be the case, it would
mean that the incidence of DAA is even higher than that
we observed in our study. Second, large variability in the
description of DAA was observed; no specific analysis of
factors associated with such variability was performed
because of the lack of several confounders. This
variability might be related to local medical practice
(i.e., use of long-term sedatives might delay awakening
and promote inappropriate WLST), limitations of care
procedures (i.e., different timing for WLST might influ-
ence the possibility that some patients eventually awake
later), or medical files quality. Third, awakening and
obeying commands cannot be entirely considered as a
“good neurologic outcome”; some patients with a CPC
of 3 (i.e., conscious with severe cerebral disability)
might present with the same definition used for DAA
and still are categorized as “poor neurologic outcome”
in all studies. Fourth, we did not collect data on
non-survivors due to severe HIE or on survivors; these
data might have provided additional comparisons on
the reasons of death, time of death, and prognostication
tools among groups. Fifth, prognostic indices were
available only for a small proportion of these patients.
This occurred because prognostication was not system-
atically performed in some participating ICUs and also
because some patients awakened before prognostica-
tion, i.e., within the first 1–2 days after ROSC. Sixth,
only the main cause of death was reported and no in-
formation on withdrawal or limitation of life-sustaining
therapies decisions was collected. Also, we missed the
clinical information on the pre-arrest condition of the
patients, such as the Charlson comorbidity index, in
particular for IHCA patients; this information might
have influenced restrictions of life-sustaining therapies
in some patients. The lack of specific ICU scores, such
as the Acute Physiology And Chronic Health Evaluation
(APACHE) II or Sequential Organ Failure Assessment
(SOFA) scores, although not validated in the CA
population, might also have been interesting to further
characterize the severity of the study population. Sev-
enth, the definition of “early” and “late” deaths was ar-
bitrary and based on the median number of days from
awakening to death and could not correspond to a clin-
ically relevant time point. Finally, the lack of additional
data on hemodynamics and ventilatory management
limited further analyses on predictors of death and
quality of care provided to such patients.
Conclusions
4.2% of CA survivors admitted to ICU eventually die
after regaining consciousness. This phenomenon has a
large variability between reporting sites. These findings
should be reported in neuroprognostication studies and
may be helpful for the design of future trials assessing
neuroprotective interventions.
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